Company Filing History:
Years Active: 2025
Title: Eleonora Loi: Pioneering Cancer Diagnosis Methods in Cagliari
Introduction
Eleonora Loi is an innovative inventor based in Cagliari, Italy, recognized for her significant contributions to cancer diagnostics. With a profound focus on the biliary tract, she has developed a method that holds promise for early-stage detection of neoplasms, enhancing patient care and treatment outcomes.
Latest Patents
Eleonora Loi holds one notable patent titled "Method for the diagnosis and/or prognosis of cancer of the biliary tract." This invention, implemented in vitro, is particularly beneficial for diagnosing both benign and malignant neoplasms in the biliary tract. The method leverages the measurement of hypermethylation levels of a genetic locus in nucleic acids extracted from tumor tissues, as well as minimally and non-invasive samples from patients. By comparing these levels to the same markers in non-tumor samples, this approach aims to provide a reliable early-stage diagnosis or prognosis. Alongside her method, a kit for executing this diagnostic process is also included in her patent.
Career Highlights
Currently affiliated with the Università Degli Studi di Cagliari, Eleonora Loi has made remarkable strides in her research career, emphasizing innovative approaches to cancer diagnosis. Her dedication to advancing the medical field is evident through her development of cutting-edge methodologies that can transform patient diagnostics.
Collaborations
Eleonora collaborates closely with esteemed colleagues, including Patrizia Zavattari and Mario Scartozzi. Together, they contribute to research that enhances the understanding and diagnosis of biliary tract cancers, demonstrating the value of teamwork in scientific advancements.
Conclusion
Eleonora Loi is a vital figure in the realm of cancer research and diagnostics. Her pioneering methods for diagnosing biliary tract cancer not only exemplify her innovative spirit but also hold the potential to significantly improve patient outcomes. As she continues her work at the Università Degli Studi di Cagliari, her future contributions are keenly anticipated in the ongoing fight against cancer.